 |
Previous Article | Next Article 
The Journal of Neuroscience, November 15, 1999, 19(22):9813-9820
Neuronal Death and Blood-Brain Barrier Breakdown after
Excitotoxic Injury Are Independent Processes
Zu-lin
Chen1, 2,
Justin
A.
Indyk1, 2, 3,
Thomas H.
Bugge4,
Keith W.
Kombrinck4,
Jay L.
Degen4, and
Sidney
Strickland1, 2
1 Department of Pharmacology, 2 Program in
Genetics, and 3 Medical Scientist Training Program,
University at Stony Brook, Stony Brook, New York 11794-8651, and
4 Division of Developmental Biology, Children's Hospital
Research Foundation, Cincinnati, Ohio 45229
Neuronal damage in the CNS after excitotoxic injury is correlated
with blood-brain barrier (BBB) breakdown. We have used a glutamate
analog injection model and genetically altered mice to investigate the
relationship between these two processes in the hippocampus. Our
results show that BBB dysfunction occurs too late to initiate
neurodegeneration. In addition, plasma infused directly into the
hippocampus is not toxic and does not affect excitotoxin-induced neuronal death. To test plasma protein
recruitment in neuronal degeneration, we used plasminogen-deficient
(plg / ) mice, which are resistant to
excitotoxin-induced degeneration. Plasminogen is produced in the
hippocampus and is also present at high levels in plasma, allowing us
to determine the contribution of each source to cell death.
Intrahippocampal delivery of plasminogen to plg /
mice restored degeneration to wild-type levels, but intravenous delivery of plasminogen did not. Finally, although the neurons in
plg / mice do not die after excitotoxin
injection, BBB breakdown occurs to a similar extent as in wild-type
mice, indicating that neuronal death is not necessary for BBB
breakdown. These results indicate that excitotoxin-induced neuronal
death and BBB breakdown are separable events in the hippocampus.
Key words:
plasminogen; tPA; neurodegeneration; blood-brain
barrier; kainate; hippocampus; mouse
Copyright © 1999 Society for Neuroscience 0270-6474/99/19229813-08$05.00/0
This article has been cited by other articles:

|
 |

|
 |
 
J. P. Lopez-Atalaya, B. D. Roussel, C. Ali, E. Maubert, K.-U. Petersen, V. Berezowski, R. Cecchelli, C. Orset, and D. Vivien
Recombinant Desmodus rotundus Salivary Plasminogen Activator Crosses the Blood-Brain Barrier Through a Low-Density Lipoprotein Receptor-Related Protein-Dependent Mechanism Without Exerting Neurotoxic Effects
Stroke,
March 1, 2007;
38(3):
1036 - 1043.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. R. Parathath, S. Parathath, and S. E. Tsirka
Nitric oxide mediates neurodegeneration and breakdown of the blood-brain barrier in tPA-dependent excitotoxic injury in mice
J. Cell Sci.,
January 15, 2006;
119(2):
339 - 349.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Benchenane, V. Berezowski, C. Ali, M. Fernandez-Monreal, J. P. Lopez-Atalaya, J. Brillault, J. Chuquet, A. Nouvelot, E. T. MacKenzie, G. Bu, et al.
Tissue-Type Plasminogen Activator Crosses the Intact Blood-Brain Barrier by Low-Density Lipoprotein Receptor-Related Protein-Mediated Transcytosis
Circulation,
May 3, 2005;
111(17):
2241 - 2249.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. S. Heinemann, G. Korza, and J. Ozols
A Plasminogen-like Protein Selectively Degrades Stearoyl-CoA Desaturase in Liver Microsomes
J. Biol. Chem.,
October 31, 2003;
278(44):
42966 - 42975.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z.-L. Chen, J. A. Indyk, and S. Strickland
The Hippocampal Laminin Matrix Is Dynamic and Critical for Neuronal Survival
Mol. Biol. Cell,
July 1, 2003;
14(7):
2665 - 2676.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. T. Liberatore, A. Samson, C. Bladin, W.-D. Schleuning, and R. L. Medcalf
Vampire Bat Salivary Plasminogen Activator (Desmoteplase): A Unique Fibrinolytic Enzyme That Does Not Promote Neurodegeneration
Stroke,
February 1, 2003;
34(2):
537 - 543.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Xue and M. R. Del Bigio
Acute Tissue Damage After Injections of Thrombin and Plasmin into Rat Striatum
Stroke,
September 1, 2001;
32(9):
2164 - 2169.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. H. Yang, P. Carmeliet, and J. A. Hamilton
Tissue-Type Plasminogen Activator Deficiency Exacerbates Arthritis
J. Immunol.,
July 15, 2001;
167(2):
1047 - 1052.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Akassoglou, K. W. Kombrinck, J. L. Degen, and S. Strickland
Tissue Plasminogen Activator-mediated Fibrinolysis Protects Against Axonal Degeneration and Demyelination after Sciatic Nerve Injury
J. Cell Biol.,
May 29, 2000;
149(5):
1157 - 1166.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|